Cerebrolysin
Cognitive & neuro Approved · Russia, China & parts of Europe Human trials
Also called FPE 1070
Not a single compound but a mixture of small peptides and amino acids made from pig brain tissue. The fragments are small enough to cross into the brain, where they are proposed to act like the body's own nerve growth factors.
Evidence at a glance
- Evidence
- Human trials — Studied in people
- Status
- An approved medicine in Russia, China & parts of Europe
- Dosing
- A dose has been tested in humans
An animal-derived mixture with no defined composition, which makes batch consistency a real question and the active component unidentified. Trial results are genuinely mixed, and the positive ones cluster in the countries where it is marketed. Western regulators have never approved it.
What studies report
- Modest cognitive improvement in Alzheimer's trials
- Mixed results in stroke recovery; the large CARS trial reported benefit, others did not
- Studied in traumatic brain injury with inconsistent outcomes
How it works
Described as neurotrophic — mimicking nerve growth factors that support neuron survival and repair — alongside reported protection against oxidative damage.
Where it acts
BrainThe library groups this compound under Cognitive & neuro. The diagram shows that target, not every tissue it reaches.
Illustrated
AI-generated subject illustration; not a depiction of the compound or evidence of its effects.
Why people take it
Reasons people seek it out — not a list of proven effects.
In practice Off-label
- Used in courses of daily injections over weeks rather than continuously
- Long established in Russian and Chinese neurology, essentially unknown in US practice
Reported real-world use, not evidence and not a recommendation.
Dosing
What was tested Evidence
- 10–30 mL daily, intravenous4 weeks, in repeated coursesAlzheimer's and stroke trials→ Modest cognitive improvement in some trials; others negative
What people report using Not evidence
- 5–10 mL daily in courses of several weeks
Reported for reference, not as instruction. Nothing here is a recommendation to take anything, and most of these compounds are not approved for human use.
Status: Approved and widely used in Russia, China and parts of Eastern Europe. Not approved by the FDA or EMA.
- Route
- Intravenous infusion or intramuscular injection, in courses
- Available as
- Ampoules for injection
Search PubMed for Cerebrolysin → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.
Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.